Related Experiment Video
Updated: Mar 28, 2026

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
Regulation of Biobanks in France
Emmanuelle Rial-Sebbag1, Anna Pigeon2
1Permanent researcher in biolaw and bioethics at Inserm (French National Institute for research and health). Graduated from Toulouse and Bordeaux Universities, she has defended her thesis on the issues raised by the governance of biobanks at Paul Sabatier University in Toulouse. She is leading the ELSI common service of the French infrastructure "Biobanques."
Abstract:
The privacy of biobank research participants in France is protected by a combination of bioethics laws, research laws, and data protection laws. Although the law has attempted to facilitate research by creating an opt-out regime for research with pre-existing samples, other aspects of the law hinder research. The requirement for multiple consents throughout the process of biobank sample collection and use, the lack of acceptance of a broad consent for biobanking, and genetic exceptionalism in the law all complicate biobank research. With IRB approval, opt-out consent may be used for genetic research using human tissue collected for other purposes, but express consent is still required for research with the associated genetic data. Among the important issues remaining to be addressed are harmonizing and simplifying the various informed consent processes.
Related Concept Videos
Bioequivalence studies: Biowaivers
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Drug Products: Biologics, Biosimilars and Interchangeables
Bioavailability Study Design: Healthy Subjects Versus Patients

